Enzon Pharmaceuticals, Inc.

ENZN

$0.30

+41.18% (1 year change)

Avg closing price

Price range

Market Cap

$22.3 Million

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$8 Thousand

Total revenue in the last quarter.

Net Income

-$407 Thousand

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

-$0.03

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-19.41x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$-407 Thousand

Earnings before interest expenses and taxes in the last quarter.

Employees

0

The number of full time employees.

Revenue & Earnings

Balance Sheet

Enzon Pharmaceuticals, Inc.

Enzon Pharmaceuticals, Inc is a pharmaceutical company engaged in developing therapeutics to patients whose needs are unmet. Its headquarters is now in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the symbol "ENZN". It's also doing marketing works in Asia areas such as China. In 2012, the company orally presented in Nanjing, China about the symposium of its drug delivery systems, which help improve therapeutic molecules' pharmaceutical properties.